IlluminOss Medical received FDA 510(k) clearance to market a Light-Emitting Diode (LED) Console to speed curing of its patented, light-cured implants.
IlluminOss has developed balloon-like implants to support and repair fragile and geriatric bone. The implants are inserted through a minimally invasive procedure into the patient’s bone canal and infused with light-curing liquid. Next, a fiber optic cable transfers a specific wavelength of blue light from the Light Console to cure the implant. The new Console reduces the implant hardening time, in some cases by up to 50%, which may decrease operative time and save hospital costs. By providing structural strength to fractured or weakened bone, IlluminOss implants provide patients with an opportunity for early mobility and return to daily living activities while also delivering a strong attachment for surgical plates and screws if necessary.
Although the original IlluminOss Light Console performs well, the company has embraced modern technologies with this new design to improve efficiency while reducing Console size by approximately 40%. The most important advancement is incorporating LEDs as the light source instead of a metal halide bulb. LEDs last much longer than bulbs and speed the curing time of the liquid inside the balloons.
IlluminOss Medical received FDA 510(k) clearance to market a Light-Emitting Diode (LED) Console to speed curing of its patented, light-cured implants.
IlluminOss has developed balloon-like implants to support and repair fragile and geriatric bone. The implants are inserted through a minimally invasive procedure into the patient’s bone canal...
IlluminOss Medical received FDA 510(k) clearance to market a Light-Emitting Diode (LED) Console to speed curing of its patented, light-cured implants.
IlluminOss has developed balloon-like implants to support and repair fragile and geriatric bone. The implants are inserted through a minimally invasive procedure into the patient’s bone canal and infused with light-curing liquid. Next, a fiber optic cable transfers a specific wavelength of blue light from the Light Console to cure the implant. The new Console reduces the implant hardening time, in some cases by up to 50%, which may decrease operative time and save hospital costs. By providing structural strength to fractured or weakened bone, IlluminOss implants provide patients with an opportunity for early mobility and return to daily living activities while also delivering a strong attachment for surgical plates and screws if necessary.
Although the original IlluminOss Light Console performs well, the company has embraced modern technologies with this new design to improve efficiency while reducing Console size by approximately 40%. The most important advancement is incorporating LEDs as the light source instead of a metal halide bulb. LEDs last much longer than bulbs and speed the curing time of the liquid inside the balloons.
Copy to clipboard 
